Vabomere Injection, Powder, For Solution
NDC Package 70842-120-06
Package Information
Vabomere (meropenem-vaborbactam) injection is a medication used to treat a variety of bacterial infections. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Melinta Therapeutics, Llc, this product is identified by NDC 70842-120 and is authorized under FDA application NDA209776.
Identification & Billing
- RxCUI: 1945218 - meropenem / vaborbactam 2 GM Injection
- RxCUI: 1945218 - meropenem 1000 MG / vaborbactam 1000 MG Injection
- RxCUI: 1945218 - meropenem 1 GM / vaborbactam 1 GM Injection
- RxCUI: 1946651 - VABOMERE 2 GM Injection
- RxCUI: 1946651 - meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70842 - Melinta Therapeutics, Llc
- 70842-120 - Vabomere
- 70842-120-06 - 6 VIAL, SINGLE-DOSE in 1 CARTON / 2 g in 1 VIAL, SINGLE-DOSE (70842-120-01)
- 70842-120 - Vabomere
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70842-120-06 identifies a specific commercial package of 6 vial, single-dose in 1 carton / 2 g in 1 vial, single-dose (70842-120-01) of Vabomere, a human prescription drug labeled by Melinta Therapeutics, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, powder, for solution is formulated for intravenous use and contains meropenem; vaborbactam as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Melinta Therapeutics, Llc on October 02, 2017. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This product is used to treat a variety of bacterial infections. It contains 2 different medications: meropenem and vaborbactam. Meropenem is a carbapenem-type antibiotic that works by stopping the growth of bacteria. Vaborbactam is an enzyme inhibitor (beta-lactamase inhibitor) that helps meropenem work better.
How is this Melinta Therapeutics, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70842012006. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
